Upgrade to SI Premium - Free Trial

Enanta Pharma (ENTA)

11.40 -0.33 (2.81%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference May 28, 2026 7:00 AM - BizWire Form S-8 ENANTA PHARMACEUTICALS May 13, 2026 7:26 AM - SEC Filing Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31 May 13, 2026 7:01 AM - SEC Filing Form 8-K ENANTA PHARMACEUTICALS For: May 11 May 11, 2026 4:06 PM - SEC Filing Enanta Pharma (ENTA) Tops Q2 EPS by 12c May 11, 2026 4:01 PM - StreetInsider Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026 May 11, 2026 4:01 PM - BizWire Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026 May 4, 2026 7:00 AM - BizWire Enanta begins phase 1 trial of oral KIT inhibitor for urticaria April 13, 2026 7:00 AM - StreetInsider Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria April 13, 2026 7:00 AM - BizWire Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026 April 7, 2026 7:24 AM - BizWire Jefferies stays Buy on Enanta Pharmaceuticals (ENTA) as co announces oral arguments for PFE patent case March 31, 2026 4:52 PM - StreetInsider Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI) March 30, 2026 7:00 AM - BizWire Form SCHEDULE 13G/A ENANTA PHARMACEUTICALS Filed by: VANGUARD GROUP INC March 26, 2026 6:07 PM - SEC Filing Form 8-K ENANTA PHARMACEUTICALS For: Mar 20 March 26, 2026 8:00 AM - SEC Filing Rodman & Renshaw Starts Enanta Pharmaceuticals (ENTA) at Buy March 26, 2026 6:32 AM - StreetInsider Form 4 ENANTA PHARMACEUTICALS For: Mar 11 Filed by: Vance Terry March 13, 2026 4:21 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 11 Filed by: Russell Lesley March 13, 2026 4:20 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 11 Filed by: Peterson Kristine March 13, 2026 4:18 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 11 Filed by: Hata Yujiro S March 13, 2026 4:17 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 11 Filed by: FOLETTA MARK G March 13, 2026 4:16 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 11 Filed by: CARTER BRUCE L A March 13, 2026 4:14 PM - SEC Filing Form 8-K ENANTA PHARMACEUTICALS For: Mar 11 March 12, 2026 4:06 PM - SEC Filing Full Article List